Vanguard Group’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.9M | Buy |
3,066,586
+168,319
| +6% | +$2.52M | ﹤0.01% | 2159 |
|
|
2025
Q1 | $46.8M | Buy |
2,898,267
+51,794
| +2% | +$836K | ﹤0.01% | 2114 |
|
|
2024
Q4 | $66.3M | Buy |
2,846,473
+330,553
| +13% | +$7.7M | ﹤0.01% | 2041 |
|
|
2024
Q3 | $74M | Buy |
2,515,920
+604,354
| +32% | +$17.8M | ﹤0.01% | 2017 |
|
|
2024
Q2 | $44.9M | Buy |
1,911,566
+1,414,385
| +284% | +$33.3M | ﹤0.01% | 2191 |
|
|
2024
Q1 | $18.9M | Buy |
497,181
+457,735
| +1,160% | +$17.4M | ﹤0.01% | 2631 |
|
|
2023
Q4 | $849K | Buy |
39,446
+6,369
| +19% | +$137K | ﹤0.01% | 3885 |
|
|
2023
Q3 | $405K | Sell |
33,077
-614,976
| -95% | -$7.53M | ﹤0.01% | 4111 |
|
|
2023
Q2 | $292K | Sell |
648,053
-1,349,544
| -68% | -$608K | ﹤0.01% | 4240 |
|
|
2023
Q1 | $579K | Hold |
1,997,597
| – | – | ﹤0.01% | 4083 |
|
|
2022
Q4 | $899K | Buy |
1,997,597
+110,201
| +6% | +$49.6K | ﹤0.01% | 3944 |
|
|
2022
Q3 | $993K | Sell |
1,887,396
-60,613
| -3% | -$31.9K | ﹤0.01% | 3999 |
|
|
2022
Q2 | $984K | Sell |
1,948,009
-169,314
| -8% | -$85.5K | ﹤0.01% | 4096 |
|
|
2022
Q1 | $4.87M | Sell |
2,117,323
-3,302
| -0.2% | -$7.59K | ﹤0.01% | 3543 |
|
|
2021
Q4 | $10.1M | Buy |
2,120,625
+11,865
| +0.6% | +$56.4K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $16.8M | Buy |
2,108,760
+11,594
| +0.6% | +$92.2K | ﹤0.01% | 2957 |
|
|
2021
Q2 | $14.6M | Sell |
2,097,166
-76,896
| -4% | -$535K | ﹤0.01% | 3008 |
|
|
2021
Q1 | $17.2M | Buy |
2,174,062
+222,838
| +11% | +$1.76M | ﹤0.01% | 2860 |
|
|
2020
Q4 | $15.4M | Buy |
1,951,224
+101,770
| +6% | +$801K | ﹤0.01% | 2768 |
|
|
2020
Q3 | $13.1M | Buy |
1,849,454
+3,958
| +0.2% | +$28.1K | ﹤0.01% | 2654 |
|
|
2020
Q2 | $17.1M | Buy |
1,845,496
+661,190
| +56% | +$6.12M | ﹤0.01% | 2500 |
|
|
2020
Q1 | $5.52M | Buy |
1,184,306
+4,142
| +0.4% | +$19.3K | ﹤0.01% | 2934 |
|
|
2019
Q4 | $9.02M | Buy |
1,180,164
+50,916
| +5% | +$389K | ﹤0.01% | 2907 |
|
|
2019
Q3 | $8.68M | Buy |
1,129,248
+24,550
| +2% | +$189K | ﹤0.01% | 2889 |
|
|
2019
Q2 | $7.57M | Sell |
1,104,698
-5,514
| -0.5% | -$37.8K | ﹤0.01% | 3009 |
|
|
2019
Q1 | $8.94M | Buy |
1,110,212
+330,008
| +42% | +$2.66M | ﹤0.01% | 2886 |
|
|
2018
Q4 | $5.84M | Buy |
780,204
+27,173
| +4% | +$204K | ﹤0.01% | 3018 |
|
|
2018
Q3 | $7.21M | Buy |
753,031
+55,193
| +8% | +$528K | ﹤0.01% | 3086 |
|
|
2018
Q2 | $7.38M | Buy |
697,838
+360,415
| +107% | +$3.81M | ﹤0.01% | 3050 |
|
|
2018
Q1 | $3.35M | Buy |
337,423
+66,171
| +24% | +$656K | ﹤0.01% | 3291 |
|
|
2017
Q4 | $1.47M | Buy |
271,252
+110,867
| +69% | +$600K | ﹤0.01% | 3514 |
|
|
2017
Q3 | $760K | Buy |
160,385
+9,611
| +6% | +$45.5K | ﹤0.01% | 3662 |
|
|
2017
Q2 | $579K | Buy |
150,774
+12,966
| +9% | +$49.8K | ﹤0.01% | 3698 |
|
|
2017
Q1 | $1.03M | Buy |
137,808
+82,850
| +151% | +$617K | ﹤0.01% | 3572 |
|
|
2016
Q4 | $239K | Buy |
54,958
+40,322
| +275% | +$175K | ﹤0.01% | 3864 |
|
|
2016
Q3 | $94K | Buy |
+14,636
| New | +$94K | ﹤0.01% | 3984 |
|